TRAIL resistance in several cancer cells was due to the decreased expression of the TRAIL receptors DR4 and DR5 (containing death domain) or increased decoy receptors DcR1 and DcR2 expression [56, 57]. This evidence concerns the gene TNFRSF10B and cancer.